Encompass Health (EHC) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $127.77, +0.96% vs the prior close of $126.56.
- Volume 1.11M shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EHC rises 1.0% to $127.77, a 52-week high. Closed at $127.77, +0.96% vs the prior close of $126.56. Day range $127.50–$129.96, opened at $128.74.
EHC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — EHC rises 1.0% to $127.77, a 52-week high
- Closed at $127.77, +0.96% vs the prior close of $126.56. Day range $127.50–$129.96, opened at $128.74.
- Volume was 1.11M shares, 1.2x its 50-day average of 925.28K.
- Price is +4.3% vs its 50-day average ($122.51) and +17.3% vs its 200-day average ($108.93).
- 52-week range $92.77–$129.96; today's close sits at 94% of that range, 1.7% below the 52-week high.
Oct 14, 2026 — EHC rises 1.8% to $126.56, a 6-month high
- Closed at $126.56, +1.79% vs the prior close of $124.33. Day range $124.71–$126.66, opened at $124.88.
- Volume was 737.70K shares, 0.8x its 50-day average of 932.42K.
- Price is +3.6% vs its 50-day average ($122.17) and +16.3% vs its 200-day average ($108.83).
- 52-week range $92.77–$127.99; today's close sits at 96% of that range, 1.1% below the 52-week high.
Oct 13, 2026 — EHC ends flat (-0.1%) to $124.33
- Closed at $124.33, -0.07% vs the prior close of $124.42. Day range $123.66–$125.32, opened at $125.32.
- Volume was 606.70K shares, 0.6x its 50-day average of 943.01K.
- Price is +2.0% vs its 50-day average ($121.85) and +14.3% vs its 200-day average ($108.73).
- 52-week range $92.77–$127.99; today's close sits at 90% of that range, 2.9% below the 52-week high.
Oct 12, 2026 — EHC rises 0.9% to $124.42, 3 up days in a row
- Closed at $124.42, +0.88% vs the prior close of $123.33. Day range $123.68–$126.36, opened at $123.68.
- Volume was 1.06M shares, 1.1x its 50-day average of 931.86K.
- Price is +2.3% vs its 50-day average ($121.61) and +14.5% vs its 200-day average ($108.65).
- 52-week range $92.77–$127.99; today's close sits at 90% of that range, 2.8% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — EHC rises 0.6% to $123.33
- Closed at $123.33, +0.64% vs the prior close of $122.54. Day range $121.43–$124.23, opened at $122.21.
- Volume was 604.40K shares, 0.6x its 50-day average of 930.13K.
- Price is +1.6% vs its 50-day average ($121.35) and +13.6% vs its 200-day average ($108.56).
- 52-week range $92.77–$127.99; today's close sits at 87% of that range, 3.6% below the 52-week high.
Oct 8, 2026 — EHC ends flat (+0.0%) to $122.54
- Closed at $122.54, +0.05% vs the prior close of $122.48. Day range $121.94–$123.59, opened at $122.35.
- Volume was 895.70K shares, 1.0x its 50-day average of 927.39K.
- Price is +1.2% vs its 50-day average ($121.10) and +13.0% vs its 200-day average ($108.48).
- 52-week range $92.77–$127.99; today's close sits at 85% of that range, 4.3% below the 52-week high.
Oct 7, 2026 — EHC dips 1.8% to $122.48
- Closed at $122.48, -1.77% vs the prior close of $124.69. Day range $121.99–$125.55, opened at $124.86.
- Volume was 875.20K shares, 0.9x its 50-day average of 927.21K.
- Price is +1.3% vs its 50-day average ($120.92) and +13.0% vs its 200-day average ($108.40).
- 52-week range $92.77–$127.99; today's close sits at 84% of that range, 4.3% below the 52-week high.
Oct 6, 2026 — EHC jumps 3.1% to $124.69, a 1-month high, 3 up days in a row
- Closed at $124.69, +3.08% vs the prior close of $120.97. Day range $120.98–$124.91, opened at $121.93.
- Volume was 1.30M shares, 1.4x its 50-day average of 909.68K.
- Price is +3.2% vs its 50-day average ($120.79) and +15.1% vs its 200-day average ($108.32).
- 52-week range $92.77–$127.99; today's close sits at 91% of that range, 2.6% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — EHC rises 1.0% to $120.97
- Closed at $120.97, +0.98% vs the prior close of $119.80. Day range $118.97–$122.66, opened at $119.71.
- Volume was 1.06M shares, 1.2x its 50-day average of 904.78K.
- Price is +0.3% vs its 50-day average ($120.58) and +11.8% vs its 200-day average ($108.24).
- 52-week range $92.77–$127.99; today's close sits at 80% of that range, 5.5% below the 52-week high.
Oct 2, 2026 — EHC rises 0.6% to $119.80
- Closed at $119.80, +0.62% vs the prior close of $119.06. Day range $118.39–$120.89, opened at $119.22.
- Volume was 1.11M shares, 1.3x its 50-day average of 890.95K.
- Price is -0.5% vs its 50-day average ($120.41) and +10.7% vs its 200-day average ($108.18).
- 52-week range $92.77–$127.99; today's close sits at 77% of that range, 6.4% below the 52-week high.
EHC latest news & SEC filings
Every SEC filing by or about EHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Price Andrew L sold 5,211 shares at $120.93 (≈$630.17K) on Aug 31, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Darby John Patrick sold 4,858 shares at $121.09 (≈$588.26K) on Aug 31, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 31, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 19, 2026 · S-3ASR — S-3ASR filing
S-3ASR filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Coltharp Douglas E sold 18,869 shares at $125.38 (≈$2.37M) on Aug 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tarr Mark J sold 171,569 shares at $125.46 (≈$21.53M) on Aug 10, 2026
- Tarr Mark J sold 1,579 shares at $126.06 (≈$199.05K) on Aug 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Darby John Patrick sold 8,906 shares at $125.95 (≈$1.12M) on Aug 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.60B (prior year $1.46B) (+9.6% vs Jun 30, 2025)
- Net income: $153.90M (prior year $142.10M) (+8.3% vs Jun 30, 2025)
- Diluted EPS: $1.54 (prior year $1.39) (+10.8% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade EHC
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 5, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.97% (largest 3.1%). That is a relatively calm stock.
- Liquidity: about 976.47K shares (≈$124.76M) trade per day on average.
- 52-week position: $127.77 vs a range of $92.77–$129.96 (94% of the range).
- Dividends: last ex-dividend date Oct 1, 2026 ($0.21/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 18 sales; latest: John Patrick Darby sold 4,858 shares on Aug 31, 2026.
- Latest filings: 8-K Aug 13, 2026; 10-Q Aug 7, 2026; 8-K Aug 5, 2026.
- Share count: 98.65M shares outstanding (Jul 28, 2026), -2.1% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Services-Hospitals.
EHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 128.74 | 129.96 | 127.50 | 127.77 | 1.11M |
| Oct 14, 2026 | 124.88 | 126.66 | 124.71 | 126.56 | 737.70K |
| Oct 13, 2026 | 125.32 | 125.32 | 123.66 | 124.33 | 606.70K |
| Oct 12, 2026 | 123.68 | 126.36 | 123.68 | 124.42 | 1.06M |
| Oct 9, 2026 | 122.21 | 124.23 | 121.43 | 123.33 | 604.40K |
| Oct 8, 2026 | 122.35 | 123.59 | 121.94 | 122.54 | 895.70K |
| Oct 7, 2026 | 124.86 | 125.55 | 121.99 | 122.48 | 875.20K |
| Oct 6, 2026 | 121.93 | 124.91 | 120.98 | 124.69 | 1.30M |
| Oct 5, 2026 | 119.71 | 122.66 | 118.97 | 120.97 | 1.06M |
| Oct 2, 2026 | 119.22 | 120.89 | 118.39 | 119.80 | 1.11M |
| Oct 1, 2026 | 121.13 | 122.93 | 119.01 | 119.06 | 996.10K |
| Sep 30, 2026 | 123.47 | 123.47 | 121.36 | 121.49 | 897.50K |
| Sep 29, 2026 | 123.18 | 124.19 | 121.57 | 123.56 | 874.20K |
| Sep 28, 2026 | 123.39 | 125.28 | 123.13 | 124.02 | 991.10K |
| Sep 25, 2026 | 121.81 | 124.51 | 121.72 | 123.47 | 1.22M |
| Sep 24, 2026 | 122.86 | 124.54 | 121.37 | 122.01 | 849.60K |
| Sep 23, 2026 | 122.73 | 124.84 | 121.91 | 122.21 | 954.40K |
| Sep 22, 2026 | 122.06 | 125.08 | 119.48 | 122.76 | 1.14M |
| Sep 21, 2026 | 121.74 | 123.67 | 120.07 | 121.56 | 801.50K |
| Sep 18, 2026 | 123.28 | 123.44 | 120.92 | 121.75 | 1.44M |
About Encompass Health
Encompass Health (EHC) is listed on the NYSE and classified by the SEC under “Services-Hospitals”. Its business address is in BIRMINGHAM, AL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 785161.
EHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Greg D Carmichael | Director | Jul 16, 2026 |
| Edward M Iii Christie | Director | Jul 16, 2026 |
| Joan E Herman | Director | Jul 16, 2026 |
| Cain A Hayes | Director | Jul 16, 2026 |
| Leslye G Katz | Director | Jul 16, 2026 |
| Kevin J. O'Connor | Director | Jul 16, 2026 |
| Christopher R Reidy | Director | Jul 16, 2026 |
| Nancy M Schlichting | Director | Jul 16, 2026 |
| Mark J Tarr | President & CEO | Aug 11, 2026 |
| Terrance Williams | Director | Jul 16, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Douglas E Coltharp | EVP & Chief Financial Officer | Aug 11, 2026 |
| Elissa Joy Charbonneau | Chief Medical Officer | Mar 3, 2026 |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Sep 1, 2026 |
| Edmund Fay | Sr. Vice Pres. and Treasurer | Mar 10, 2026 |
| Andrew L Price | Chief Accounting Officer | Sep 1, 2026 |
| Mark J Tarr | President & CEO | Aug 11, 2026 |
| Patrick William Tuer | EVP, Chief Operating Officer | May 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | John Patrick Darby | Sale | 4,858 | $121.09 |
| Aug 31, 2026 | Andrew L Price | Sale | 5,211 | $120.93 |
| Aug 10, 2026 | Douglas E Coltharp | Sale | 18,869 | $125.38 |
| Aug 10, 2026 | Mark J Tarr | Sale | 171,569 | $125.46 |
| Aug 10, 2026 | Mark J Tarr | Sale | 1,579 | $126.06 |
| Aug 10, 2026 | John Patrick Darby | Sale | 8,906 | $125.95 |
| May 15, 2026 | Douglas E Coltharp | Sale | 1 | $107.28 |
| May 15, 2026 | Douglas E Coltharp | Sale | 27,693 | $106.83 |
| May 11, 2026 | Patrick William Tuer | Sale | 682 | $104.56 |
| Mar 9, 2026 | Edmund Fay | Sale | 11,937 | $107.00 |
| Feb 11, 2026 | Mark J Tarr | Sale | 6,057 | $111.89 |
| Feb 11, 2026 | Mark J Tarr | Sale | 10,954 | $110.92 |
| Feb 11, 2026 | Mark J Tarr | Sale | 15,584 | $110.07 |
| Feb 11, 2026 | Mark J Tarr | Sale | 13,231 | $108.80 |
| Feb 11, 2026 | Mark J Tarr | Sale | 16,216 | $108.03 |
EHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $5.94B | $566.20M | 5.54 | — |
| Dec 31, 2024 | $5.37B | $455.70M | 4.46 | — |
| Dec 31, 2023 | $4.80B | $352.00M | 3.47 | — |
| Dec 31, 2022 | $4.35B | $271.00M | 2.70 | $705.80M |
| Dec 31, 2021 | $4.01B | $412.20M | 4.11 | $715.80M |
Latest balance sheet: total assets $7.46B, total liabilities $4.00B, cash $107.70M (as of Jun 30, 2026).
EHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $110.90 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $100.00 |
| Feb 5, 2026 | 8-K Item 2.02 (results) | $99.56 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $125.63 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $109.50 |
| Apr 24, 2025 | 8-K Item 2.02 (results) | $101.41 |
| Feb 6, 2025 | 8-K Item 2.02 (results) | $98.60 |
| Oct 28, 2024 | 8-K Item 2.02 (results) | $93.09 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| Apr 24, 2024 | 8-K Item 2.02 (results) | — |
| Feb 7, 2024 | 8-K Item 2.02 (results) | — |
| Oct 26, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Hospitals
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on EHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.